Antibody Drug Conjugates (ADC) Charged With HDAC Inhibitor for Targeted Epigenetic Modulation

Chemical Science - United Kingdom
doi 10.1039/c7sc05266a
Full Text
Abstract

Available in full text

Categories
Chemistry
Date
Authors
Publisher

Royal Society of Chemistry (RSC)

Related search

Antibody – Drug Conjugates (ADC) – Drug Discovery Today: Technologies

Drug Discovery Today: Technologies
BiotechnologyDrug DiscoveryMolecular Medicine
2018English

Epigenetic Modulation With Oral Histone Deacetylase (HDAC) Inhibitor as a New Treatment Option in JIA

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2011English

Epigenetic Modulation With HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells

PLoS ONE
Multidisciplinary
2015English

Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)—Is There Still Room for Optimism?

Frontiers in Oncology
Cancer ResearchOncology
2019English

Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) Is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Epigenetic-Targeted Drug Discovery

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2011English

Site-Specific Antibody Drug Conjugates for Cancer Therapy

mAbs
AllergyImmunology
2013English

Antibody-Drug Conjugates in Bladder Cancer

Bladder Cancer
OncologyUrology
2018English

The Promise of Antibody–Drug Conjugates

New England Journal of Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy